DK1815850T3 - Controlled release formular af valproinsyreforbindelse og dets derivater - Google Patents
Controlled release formular af valproinsyreforbindelse og dets derivaterInfo
- Publication number
- DK1815850T3 DK1815850T3 DK06250124T DK06250124T DK1815850T3 DK 1815850 T3 DK1815850 T3 DK 1815850T3 DK 06250124 T DK06250124 T DK 06250124T DK 06250124 T DK06250124 T DK 06250124T DK 1815850 T3 DK1815850 T3 DK 1815850T3
- Authority
- DK
- Denmark
- Prior art keywords
- controlled release
- acid compound
- valproic acid
- derivatives
- release form
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06250124A EP1815850B1 (de) | 2006-01-11 | 2006-01-11 | Formulierung zur verzögerten Freisetzung von Valproinsäure und deren Derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1815850T3 true DK1815850T3 (da) | 2009-03-16 |
Family
ID=36250729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06250124T DK1815850T3 (da) | 2006-01-11 | 2006-01-11 | Controlled release formular af valproinsyreforbindelse og dets derivater |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1815850B1 (de) |
AT (1) | ATE415151T1 (de) |
DE (1) | DE602006003848D1 (de) |
DK (1) | DK1815850T3 (de) |
ES (1) | ES2317450T3 (de) |
PL (1) | PL1815850T3 (de) |
PT (1) | PT1815850E (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201417828D0 (en) | 2014-10-08 | 2014-11-19 | Cereno Scient Ab | New methods and compositions |
WO2017175013A1 (en) * | 2016-04-08 | 2017-10-12 | Cereno Scientific Ab | Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof |
CN107811985B (zh) * | 2016-09-13 | 2021-05-28 | 四川科瑞德制药股份有限公司 | 一种抗癫痫缓释制剂及其制备方法与用途 |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4988731A (en) | 1979-08-20 | 1991-01-29 | Abbott Laboratories | Sodium hydrogen divalproate oligomer |
US5212326A (en) | 1979-08-20 | 1993-05-18 | Abbott Laboratories | Sodium hydrogen divalproate oligomer |
US4369172A (en) | 1981-12-18 | 1983-01-18 | Forest Laboratories Inc. | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose |
US5185159A (en) | 1983-07-20 | 1993-02-09 | Sanofi | Pharmaceutical composition based on valproic acid and a process for preparing it |
US4913906B1 (en) | 1985-02-28 | 2000-06-06 | Yissum Res Dev Co | Controlled release dosage form of valproic acid |
ES2026198T3 (es) * | 1987-07-22 | 1992-04-16 | Farvalsa Ag | Compuesto a base de acido valproico solido, estable a la humedad y metodo para su preparacion. |
GB8724763D0 (en) | 1987-10-22 | 1987-11-25 | Aps Research Ltd | Sustained-release formulations |
US5169642A (en) | 1988-06-24 | 1992-12-08 | Abbott Laboratories | Sustained-release drug dosage units |
US5009897A (en) | 1988-06-24 | 1991-04-23 | Abbott Laboratories | Pharmaceutical granules and tablets made therefrom |
FR2643556B1 (fr) | 1989-02-27 | 1993-03-05 | Sanofi Sa | Composition pharmaceutique a liberation prolongee d'acide valproique |
ES2143481T3 (es) | 1992-05-29 | 2000-05-16 | Nikken Chemicals Co Ltd | Comprimido de valproato de sodio de liberacion lenta. |
US6287598B1 (en) | 1993-05-28 | 2001-09-11 | Alza Corporation | Method for providing sustained antiepileptic therapy |
US6419953B1 (en) | 1998-12-18 | 2002-07-16 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
US6528090B2 (en) | 1998-12-18 | 2003-03-04 | Abbott Laboratories | Controlled release formulation of divalproex sodium |
AT408718B (de) * | 1999-12-02 | 2002-02-25 | Gerot Pharmazeutika | Natriumvalproat-granulat mit verringerter hygroskopizität |
-
2006
- 2006-01-11 PT PT06250124T patent/PT1815850E/pt unknown
- 2006-01-11 EP EP06250124A patent/EP1815850B1/de active Active
- 2006-01-11 DE DE602006003848T patent/DE602006003848D1/de active Active
- 2006-01-11 DK DK06250124T patent/DK1815850T3/da active
- 2006-01-11 AT AT06250124T patent/ATE415151T1/de not_active IP Right Cessation
- 2006-01-11 PL PL06250124T patent/PL1815850T3/pl unknown
- 2006-01-11 ES ES06250124T patent/ES2317450T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
EP1815850B1 (de) | 2008-11-26 |
PT1815850E (pt) | 2009-01-06 |
EP1815850A1 (de) | 2007-08-08 |
PL1815850T3 (pl) | 2009-05-29 |
ATE415151T1 (de) | 2008-12-15 |
ES2317450T3 (es) | 2009-04-16 |
DE602006003848D1 (de) | 2009-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1485080T3 (da) | Anvendelse af adapalen til behandling af dermatologiske sygdomme | |
UA106199C2 (ru) | Производные аминобензамида как агенты, пригодные для использования для борьбы с паразитами животных | |
CY1115199T1 (el) | Κυτταροτοξικοι παραγοντες που περιεχουν νεα παραγωγα τομαϋμυκινης και η θεραπευτικη τους χρηση | |
CY1112831T1 (el) | Παραγωγα αζαβιρηενυlαμινοβενζοιc acid σαν παραγοντες καταστολης dhodh | |
MX2011012122A (es) | Derivados de tiofeno. | |
PA8622401A1 (es) | Derivados de acido 7-fenilamino-4-quinolona-3-carboxilico,procesos para su preparacion y su uso como medicamentos | |
MX2007012443A (es) | Formulaciones farmaceuticas orales que comprenden acido fenofibrico y/o sus sales. | |
CY1113267T1 (el) | Παραγωγα θειοφαινιου ως αγωνιστες των υποδοσεων s1p1/edg1 | |
HRP20090017T3 (en) | 3,11b-cis-dihydrotetrabenazine for the treatment of a proliferative disease or an inflammation | |
RS53209B (en) | PHARMACEUTICAL COMPOSITION FOR VIRAL HEPATITIS C PROTEASE INHIBITOR | |
ATE550023T1 (de) | Stabile feste zubereitung mit 4,5- epoxymorphinanderivat | |
BRPI0606606A2 (pt) | composições estáveis contendo prostaglandina | |
IL195269A0 (en) | Pharmaceutical formulations for the sustained release of active ingredient(s), as well as their applications, especially therapeutic | |
FR2901139B1 (fr) | Compositions comprenant au moins un derive de l'acide naphtoique et du peroxyde de benzoyle, leurs procedes de preparation, et leurs utilisations | |
WO2007120374A3 (en) | Anti-arenaviral compounds | |
ECSP088689A (es) | NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS | |
ITMI20061672A1 (it) | Formulazioni di acido acetilsalicilico o suoi derivati in capsule molli,esibenti elevata stabilita' | |
BR112013004455A2 (pt) | composições para fornecimento gástrico de agentes ativos | |
NO20083183L (no) | Fast farmasoytisk sammensetning inneholdende irbesartan | |
DK1815850T3 (da) | Controlled release formular af valproinsyreforbindelse og dets derivater | |
AU2005238141A8 (en) | Pentenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof | |
HRP20110459T1 (hr) | Upotreba 4-ciklopropilmetoksi-n-(3,5-diklor-1-oksidopiridin-4-il)-5-(metoksi)piridin-2-karboksamida u liječenju ozljeda kralježnične moždine | |
ATE530172T1 (de) | Pharmazeutische formulierungen mit clopidogrel | |
EA200800150A1 (ru) | Состав с пролонгированным высвобождением действующих начал лекарственного средства | |
BRPI0519840A2 (pt) | derivados de ácido fenilbenzóico, processos para preparação do mesmo, composições farmacêuticas compreendendo-os e usos terapêuticos dos mesmos |